Measured

In this weeks episode, Han is joined by Emma O'Brien. Emma wrote the play Measured, which has was fortunate enough to see a week or so ago.

Measured is a play demonstrating the impact an eating disorder can have on the individual and their loved ones. Measured begins the day Sophie, the lead character, is discharged from the hospital. Following this, Measured explore the impact of recovery on identity, "normal life", relationships, and life in general.

With Emma, we discuss the premise of Measured and how she came about writing such an incredible play. We discuss her experience, how this shaped the play, and how she gained insight from others to make sure eating disorders were portrayed in a real, informative, and thought-provoking manner.

For more information about Measured or Emma's work, you can follow Emma on twitter @scousiepie or you can find Measured @measuredfest.

You can also find the cast here:

  • Juliette Burton (Sophie) - @JulietteBurton

  • Aaron Phinehas Peters (Tom) - @aaronphinehasp

  • Cat Rob (Director) - @CatRobey

Recent Posts

By Hannah Hickinbotham October 13, 2025
Eating disorders affect more than the individual, they impact the whole family.
By Hannah Hickinbotham October 6, 2025
Discover how George Mycock's research is reshaping eating disorder support for men. Learn why inclusive, person-centred resources matter — and how services can better reach men at every stage of their journey.
By Hannah Hickinbotham September 29, 2025
What happens when your eating disorder recovery is deeply intertwined with your neurodivergence?
Nightingale Hospital, London
By Hannah Hickinbotham September 24, 2025
Nightingale Hospital is now sponsoring the Full of Beans podcast. Discover why their values align so deeply with ours and what this partnership means for the future.
By Hannah Hickinbotham September 21, 2025
Autism and anorexia might be related, but what happens if you don't know you're autistic?
Exploring the Risks of Unregulated Weight Loss Medications
By Hannah Hickinbotham September 14, 2025
Unregulated access to GLP-1 weight-loss drugs poses serious risks—particularly for those with a history of eating disorders. Here's why regulation, screening, and support must be prioritised.
Show More